Alpine Wrestling festival spotlights brawn, Swiss pride
BURGDORF, Switzerland (Reuters) - Matthias Sempach, a 27-year-old farmer and butcher, knew exactly what he had to do to earn his title on Sunday of "King of the Alpine Wrestlers":...
Home > Reviews
All Stories
Alpine Wrestling festival spotlights brawn, Swiss pride
BURGDORF, Switzerland (Reuters) - Matthias Sempach, a 27-year-old farmer and butcher, knew exactly what he had to do to earn his title on Sunday of "King of the Alpine Wrestlers":...
Roche looks to replicate cancer success with eye drugs
ZURICH (Reuters) - Positive results for Roche's experimental eye drug should bolster its position in the multibillion-dollar-a-year market for vision loss treatments, as it looks to branch out beyond its...
Roche looks to replicate cancer success with eye drugs
ZURICH (Reuters) - Positive results for Roche's experimental eye drug should bolster its position in the multibillion-dollar-a-year market for vision loss treatments, as it looks to branch out beyond its...
Alexion valuation could choke any Roche bid
ZURICH (Reuters) - Buying Alexion Pharmaceuticals Inc would help Roche make a splash in the newly lucrative area of rare or so-called orphan diseases, but it could command a price...
Dental pioneer Nobel Biocare seeks way back to sales success
ZURICH (Reuters) - When Swede Goesta Larsson died in 2006, the titanium screw-in teeth put in his mouth more than 40 years earlier were still in good working order. Now,...
Swiss take cue from EU members in corporate tax row
BERNE (Reuters) - Switzerland is considering corporate tax incentives as offered by countries like Belgium, Britain and the Netherlands as it bows to European Union pressure to scrap its own...
Roche banks on new drug data to defend cancer business
ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug,...
Roche banks on new drug data to defend cancer business
ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug,...
Analysis: Roche stays a step ahead of copycat drugmakers
ZURICH (Reuters) - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...